PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1565703
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1565703
Electrophoresis Market size was valued at USD 3,109.43 Million in 2023, expanding at a CAGR of 4.30% from 2024 to 2032.
Electrophoresis is a laboratory technique used to separate molecules, such as DNA, RNA, or proteins, based on their size, charge, and shape. This method involves applying an electric current to a gel or another medium, causing molecules to move through it. Because different molecules have varying sizes and charges, they migrate at different rates, which allows them to be separated for analysis.
Electrophoresis Market- Market Dynamics
Increasing demand from clinical diagnostics, biotech industry and prevalence of genetic diseases is expected to propel market demand
Electrophoresis plays a crucial role in clinical diagnostics, especially in areas such as immunology, hematology, and oncology. It is used to detect protein abnormalities, blood disorders, and markers related to specific diseases, making it an indispensable tool in laboratories and hospitals, thereby contributing to market growth. Governments and healthcare organizations globally are investing in biotechnology and molecular diagnostics. Funding for research initiatives and healthcare infrastructure, particularly in genomic research, encourages the use of electrophoresis technologies.
Continued advancements in genomics, proteomics, and biotechnology enhance the utility of electrophoresis in both research and clinical settings. Techniques like next-generation sequencing (NGS) require precise molecular separation methods, which can be offered by electrophoresis. Also, the growing prevalence of cancer, genetic disorders, and other chronic diseases drives demand for diagnostic tools. Electrophoresis is widely used in identifying mutations, detecting abnormalities in genetic material, and conducting molecular-level analysis for disease research. Further, increasing R&D activities in pharmaceutical and biotechnological sectors fuel demand for electrophoresis equipment.
Electrophoresis Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.30% over the forecast period (2024-2032)
Based on Product segmentation, the software segment was predicted to show maximum market share in the year 2023, owing to high adoption software system in medical sector.
Based on Application segmentation, academics & research segment was the leading Application segment in 2023, due to increasing research in drug designing, genomics, etc.
Based on End User segmentation, hospitals segment was the leading End User segment in 2023, due to increasing prevalence of genetic diseases.
On the basis of region, North America was the leading revenue generator in 2023, due to the supportive government initiatives and rising public-private partnerships.
The Global Electrophoresis Market is segmented on the basis of Product, Application, End User, and Region.
The market is divided into four categories based on Product: reagents, electrophoresis system, software, and others. The software segment dominates the market. The increasing demand for documentation system & needs is fueling market growth.
The market is divided into three categories based on Application: diagnostics, academics & research, and others. The academic & research segment dominates the market. Rising investments by pharma companies for drug discovery, genomics is supporting market growth.
The market is divided into three categories based on End User: hospitals, biopharmaceutical companies, and others. The hospitals segment dominates the market and is expected to maintain its high dominance during the forecast period. Growing healthcare infrastructure & advanced medicinal approach in treating disorders is supplementing segment growth.
Electrophoresis Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, particularly the United States, holds the largest market share in the global electrophoresis market. This dominance is driven by advanced healthcare infrastructure, significant investments in biotechnology, and the presence of major market players. The U.S. government and private institutions fund numerous biomedical and genetic research projects, boosting demand for electrophoresis in diagnostics and drug discovery. The Asia-Pacific region, particularly China, India, Japan, and South Korea, is experiencing rapid growth in the electrophoresis market. The region is becoming a hub for low-cost manufacturing of electrophoresis equipment, which makes these products more accessible and drives regional market growth.
The Electrophoresis market is moderately competitive in nature. Companies are expanding their electrophoresis portfolios to meet the needs of proteomics and genomics research, where electrophoresis is essential for separating and analyzing biomolecules. Market players are increasingly focusing on ensuring their electrophoresis systems meet stringent regulatory standards, particularly in clinical diagnostics where precision and accuracy are critical. Bio-Rad Laboratories has developed electrophoresis systems that can integrate with proteomics workflows, enhancing protein characterization and biomarker discovery.
In 2023, Advanced Electrophoresis Solutions collaborated with Medispec to enhance their reach in India.
In 2022, Takara Bio Inc. has focused on enhancing electrophoresis systems used for RNA and DNA analysis, particularly in genomic research and next-generation sequencing workflows.